Free Trial

Vor Biopharma (VOR) Earnings Date, Estimates & Call Transcripts

$1.72
-0.02 (-1.15%)
(As of 05/21/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 8Estimated
Actual EPS
(Mar. 20)
-$0.39 Beat By $0.10
Consensus EPS
(Mar. 20)
-$0.49
Skip Charts & View Estimated and Actual Earnings Data

VOR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VOR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Vor Biopharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.40)($0.36)($0.38)
Q2 20242($0.41)($0.23)($0.32)
Q3 20242($0.44)($0.23)($0.34)
Q4 20242($0.48)($0.23)($0.36)
FY 20248($1.73)($1.05)($1.39)
Q1 20251($0.24)($0.24)($0.24)
Q2 20251($0.24)($0.24)($0.24)
Q3 20251($0.23)($0.23)($0.23)
Q4 20251($0.23)($0.23)($0.23)
FY 20254($0.94)($0.94)($0.94)

VOR Earnings Date and Information

Vor Biopharma last announced its earnings data on March 20th, 2024. The reported ($0.39) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.49) by $0.10. Vor Biopharma has generated ($1.78) earnings per share over the last year (($1.78) diluted earnings per share). Earnings for Vor Biopharma are expected to grow in the coming year, from ($1.49) to ($1.24) per share. Vor Biopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.

Vor Biopharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/8/2024
(Estimated)
------- 
3/20/2024Q4 2023($0.49)($0.39)+$0.10($0.39)--
11/7/2023Q3 2023($0.46)($0.49)($0.03)($0.49)--
8/10/2023Q2 2023($0.42)($0.45)($0.03)($0.45)--
5/11/2023Q1 2023($0.38)($0.43)($0.05)($0.43)--
3/23/2023Q4 2022($0.56)($0.53)+$0.03($0.53)--
11/10/2022Q3 2022($0.60)($0.63)($0.03)($0.63)--
8/11/2022Q2 2022($0.67)($0.58)+$0.09($0.58)--
5/12/2022Q1 2022($0.54)($0.61)($0.07)($0.61)--
3/14/2022Q4 2021($0.55)($0.49)+$0.06($0.49)--
11/10/2021Q3 2021($0.62)($0.50)+$0.12($0.50)--
8/8/2021Q2 2021($0.50)($0.50)-($0.50)--
5/6/2021Q1 2021($0.83)($0.67)+$0.16($0.67)--

Vor Biopharma Earnings - Frequently Asked Questions

When is Vor Biopharma's earnings date?

Vor Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on VOR's earnings history.

Did Vor Biopharma beat their earnings estimates last quarter?

In the previous quarter, Vor Biopharma (NYSE:VOR) reported ($0.39) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.49) by $0.10. Learn more on analysts' earnings estimate vs. VOR's actual earnings.

What is Vor Biopharma's EPS forecast for next year?

Vor Biopharma's earnings are expected to grow from ($1.49) per share to ($1.24) per share in the next year.


More Earnings Resources from MarketBeat

This page (NYSE:VOR) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners